Literature DB >> 17415522

Hepatocyte growth factor in invasive growth of carcinomas.

M A Desiderio1.   

Abstract

Hepatocyte growth factor is a multifunctional cytokine of the tumor microenvironment. An important advance in the knowledge of cancer progression has been the appreciation that the tumor invasive phenotype is strongly influenced by microenvironmental stimuli. Malignant tumor cells recruit vasculature and stroma through the production of growth factors and cytokines. The locally activated microenvironment (both cellular and extracellular elements) in turn modifies the proliferative and invasive behavior of the tumor cells. Hepatocyte growth factor accomplishes most of the functions of the invasive program in carcinomas (loss of adhesive junctions, motility, angiogenesis, survival/apoptosis), and may interact with other signals such as hypoxia. The purpose of the present review is to highlight examples of the progress in this area. The influence of hepatocyte growth factors on the carcinoma invasive phenotype is considered by evaluating the gene targets and the network of transcription factors activated in the specific responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17415522     DOI: 10.1007/s00018-007-7050-x

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  15 in total

1.  SULF1 inhibits proliferation and invasion of esophageal squamous cell carcinoma cells by decreasing heparin-binding growth factor signaling.

Authors:  Chun-Tao Liu; Sheng-Tao Zhu; Peng Li; Yong-Jun Wang; Hao Zhang; Shu-Tian Zhang
Journal:  Dig Dis Sci       Date:  2012-10-05       Impact factor: 3.199

2.  c-Met inhibitor synergizes with tumor necrosis factor-related apoptosis-induced ligand to induce papillary thyroid carcinoma cell death.

Authors:  Rong Bu; Shahab Uddin; Maqbool Ahmed; Azhar R Hussain; Saif Alsobhi; Tarek Amin; Abdurahman Al-Nuaim; Fouad Al-Dayel; Jehad Abubaker; Prashant Bavi; Khawla S Al-Kuraya
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

3.  Disturbance of Ca2+ homeostasis converts pro-Met into non-canonical tyrosine kinase p190MetNC in response to endoplasmic reticulum stress in MHCC97 cells.

Authors:  Rongyang Dai; Juanjuan Li; Jing Fu; Yao Chen; Lexing Yu; Xiaofang Zhao; Youwen Qian; Huilu Zhang; Haiyang Chen; Yibin Ren; Bo Su; Tao Luo; Junjie Zhu; Hongyang Wang
Journal:  J Biol Chem       Date:  2012-03-14       Impact factor: 5.157

4.  Low temperature of radiofrequency ablation at the target sites can facilitate rapid progression of residual hepatic VX2 carcinoma.

Authors:  Shan Ke; Xue-mei Ding; Jian Kong; Jun Gao; Shao-hong Wang; Yan Cheng; Wen-bing Sun
Journal:  J Transl Med       Date:  2010-07-29       Impact factor: 5.531

5.  Des-gamma-carboxy prothrombin stimulates human vascular endothelial cell growth and migration.

Authors:  Su-Bo Wang; Yan-Na Cheng; Shu-Xiang Cui; Julia Li Zhong; S G Ward; Li-Rui Sun; Ming-Hui Chen; Norihiro Kokudo; Wei Tang; Xian-Jun Qu
Journal:  Clin Exp Metastasis       Date:  2009-03-05       Impact factor: 5.150

6.  A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-ras.

Authors:  Yanan Yang; Marie Wislez; Nobukazu Fujimoto; Ludmila Prudkin; Julie G Izzo; Futoshi Uno; Lin Ji; Amy E Hanna; Robert R Langley; Diane Liu; Faye M Johnson; Ignacio Wistuba; Jonathan M Kurie
Journal:  Mol Cancer Ther       Date:  2008-04       Impact factor: 6.261

7.  Enhancement of head and neck squamous cell carcinoma proliferation, invasion, and metastasis by tumor-associated fibroblasts in preclinical models.

Authors:  Sarah Elizabeth Wheeler; Huifang Shi; Fangchen Lin; Sumana Dasari; Joseph Bednash; Stephen Thorne; Simon Watkins; Radhika Joshi; Sufi Mary Thomas
Journal:  Head Neck       Date:  2013-06-01       Impact factor: 3.147

Review 8.  Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment.

Authors:  Larion Santiago; Garrett Daniels; Dongwen Wang; Fang-Ming Deng; Peng Lee
Journal:  Am J Cancer Res       Date:  2017-06-01       Impact factor: 6.166

9.  Galectin-3 facilitates cell motility in gastric cancer by up-regulating protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1).

Authors:  Seok-Jun Kim; Ji-Young Shin; Kang-Duck Lee; Young-Ki Bae; Il-Ju Choi; Seok Hee Park; Kyung-Hee Chun
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

10.  Sema4D, the ligand for Plexin B1, suppresses c-Met activation and migration and promotes melanocyte survival and growth.

Authors:  Joanne Soong; Yulin Chen; Elina M Shustef; Glynis A Scott
Journal:  J Invest Dermatol       Date:  2011-12-22       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.